Scientists study China's one-child policy

Apr 23, 2007

U.S. scientists conducting the first systematic examination of China's fertility policy are warning of a possible demographics crisis in that nation.

The University of California-Irvin researchers found 63 percent of Chinese couples are strictly limited to one child.

The study, which involved researchers in the United States and China, is the first to use data on fertility policy and population growth collected from 420 Chinese prefectures.

"We want to clear up confusion about the one-child policy," said Wang Feng, a University of California-Irvin sociology professor and a lead author of the study. "Despite what some say, the policy has not been (relaxed) over the years."

China's average mandated fertility rate, accounting for the variety of exceptions across the country, is 1.47 children per couple. Wang and his colleagues found the actual fertility rate is about 1.5 children per couple.

"Such convergence between policy and reality is extraordinary, even for China," he said. "With the birth rate below replacement level, the country faces serious negative consequences in the long run if it fails to phase out the policy."

The study appears in the journal Population and Development Review.

Copyright 2007 by United Press International

Explore further: Cardinal Health paying $26.8 million in FTC settlement

Related Stories

Sanitation scores in India have room for improvement

Feb 11, 2015

Sanitation scores, conferred on each of India's 421 largest cities by the national government, set a useful benchmark, say water-resources experts in Cornell's College of Agriculture and Life Sciences.

New book examines implications of an aging workforce

Feb 02, 2015

As chief of the Associated Press' Tokyo bureau, Joseph Coleman wrote a story about an agricultural cooperative in southwestern Japan where organizers put aging residents to work selling leaves and flowers ...

Recommended for you

Cardinal Health paying $26.8 million in FTC settlement

12 hours ago

Cardinal Health will pay $26.8 million as part of a settlement with the Federal Trade Commission over charges it monopolized the sale in 25 markets of diagnostic drugs known as low-energy radiopharmaceuticals.

Selecting the right tool for the job

Apr 14, 2015

Randomized clinical trials of new drugs have long been considered the "gold standard" in determining safety and efficacy before drugs, biologics, vaccines or devices are introduced to the general public. However, in the case ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.